Asset Details
Do you wish to reserve the book?
Hypothyroidism after hemithyroidectomy: a systematic review and meta-analysis
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Hypothyroidism after hemithyroidectomy: a systematic review and meta-analysis
Do you wish to request the book?
Hypothyroidism after hemithyroidectomy: a systematic review and meta-analysis
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Hypothyroidism after hemithyroidectomy: a systematic review and meta-analysis
2024
Overview
Background
The incidence of hypothyroidism following hemithyroidectomy and risk factors associated with its occurrence are not completely understood. This systematic review investigated the incidence and risk factors for hypothyroidism, thyroxine supplementation following hemithyroidectomy as well as the course of post-operative hypothyroidism, including the time to hypothyroidism and incidence of transient hypothyroidism.
Methods
Searches were conducted in MEDLINE, EMBASE, Scopus, and Cochrane library for studies reporting the incidence of hypothyroidism or thyroxine supplementation following hemithyroidectomy.
Results
Sixty-six studies were eligible for inclusion: 36 reported risk factors, and 27 reported post-operative course of hypothyroidism. Median follow-up was 25.2 months. The pooled incidence of hypothyroidism was 29% (95% CI, 25-34%;
P
<0.001). Transient hypothyroidism occurred in 34% of patients (95% CI, 21-47%;
P
<0.001). The pooled incidence of thyroxine supplementation was 23% (95% CI, 19-27%;
P
<0.001), overt hypothyroidism 4% (95% CI, 2-6%,
P
<0.001). Risk factors for development of hypothyroidism included pre-operative thyroid stimulating hormone (TSH) (WMD, 0.87; 95% CI, 0.75-0.98;
P
<0.001), TSH ≥ 2 mIU/L (RR, 2.87; 95% CI, 2.43-3.40;
P
<0.001), female sex (RR, 1.19; 95% CI, 1.08-1.32;
P
=0.007), age (WMD, 2.29; 95% CI, 1.20-3.38;
P
<0.001), right sided hemithyroidectomy (RR, 1.35; 95% CI, 1.10-1.65,
P
=0.003), the presence of autoantibodies anti-TPO (RR, 1.92; 95% CI, 1.49-2.48;
P
<0.001), anti-Tg (RR, 1.53; 95% CI, 1.40-1.88;
P
<0.001), and Hashimoto’s thyroiditis (RR, 2.05; 95% CI, 1.57-2.68;
P
=0.001).
Conclusion
A significant number of patients will develop hypothyroidism or require thyroxine following hemithyroidectomy. An awareness of patient risk factors and postoperative thyroid function course will assist in counselling patients on their risk profile and guiding management.
